The human tumor stem cell assay revisited

S. Eva Singletary, Gunter E. Umbach, Gary Spitzer, Benjamin Drewinko, Barbara Tomasovic, Jaffer Ajani, Verena Hug, George Blumenschein

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

The human tumor stem cell assay (HTSCA) is a bilayer soft agar system for growing fresh human tumor specimens in vitro to determine drug sensitivity and improve our understanding of tumor biology. Recent clinical correlations of 60% accuracy for predicting a positive clinical response and a 90% accuracy for predicting a lack of response to therapeutic agents suggest promising clinical usefulness. However, the clinician should be aware of the assay's inherent pitfalls, such as heterogeneity of the tumor specimen, inability to obtain pure single‐cell suspensions, low cloning efficiency, unusual drug dose‐dependent survival curves, uncertain validity of in vitro pharmacology, nonstandardized criteria for in vitro sensitivity, and the variability of in vitro results. A brief summary of the concepts, potential, and limitations of this assay are discussed.

Original languageEnglish (US)
Pages (from-to)116-128
Number of pages13
JournalThe International Journal of Cell Cloning
Volume3
Issue number2
DOIs
StatePublished - 1985

Keywords

  • Clonogenic assay Chemosensitivity
  • HTSCA
  • Human tumor cloning system

ASJC Scopus subject areas

  • Cell Biology

Fingerprint

Dive into the research topics of 'The human tumor stem cell assay revisited'. Together they form a unique fingerprint.

Cite this